Home
Search:
1146 feeds
357 categories
0 articles (<24 hours)
36 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

General


RSS FeedsOctober 23, 2017 - TG1050 is well tolerated and induces a strong specific immune response in patients with chronic hepatitis B
(WorldNews France)

 
 

23 october 2017 09:29:11

 
October 23, 2017 - TG1050 is well tolerated and induces a strong specific immune response in patients with chronic hepatitis B
(WorldNews France)
 


TG1050 is well tolerated and induces a strong specific immune response in patients with chronic hepatitis B Data presented at AASLD Liver Meeting 2017 Strasbourg, October 23, 2017- 7:30 am - Transgene (Euronext Paris: TNG), a biotech company that designs and develops viral-based immunotherapies, announces that the analyses conducted on patients with chronic hepatitis B receiving standard antiviral therapies and a single dose of TG1050 in the Phase 1/1b trial, confirm the good tolerability profile and demonstrate the immunogenicity of this novel therapeutic vaccine. Transgene presented a poster describing the first promising clinical data of TG1050 on October 21, 2017, at the annual meeting...


 
14 viewsCategory: General > Europe > France
 
New pension scheme agreements reached by KLM with its pilot and cabin staff unions
(WorldNews France)
`Hundreds of refugees` in Calais area despite Jungle clearance a year ago
(WorldNews France)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten